JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFPT
2601
CALL
DELISTED
Proofpoint, Inc.
PFPT
| $4.19M | ﹤0.01% |
+50,000
| New | +$4.63M |
|
2602
Comtech Telecommunications
CMTL
$50M
| $4.17M | ﹤0.01% |
171,464
+29,014
| +20% | +$813K |
|
2603
PUT
ConocoPhillips
COP
$145B
| $4.17M | ﹤0.01% |
+66,900
| New | +$4.55M |
|
|
IVC
2604
DELISTED
Invacare Corporation
IVC
| $4.17M | ﹤0.01% |
969,882
+166,875
| +21% | +$1.48M |
|
|
FTSV
2605
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $4.16M | ﹤0.01% |
264,323
-81,743
| -24% | -$1.25M |
|
2606
iShares Global Energy ETF
IXC
$2.77B
| $4.13M | ﹤0.01% |
140,837
+22,514
| +19% | +$759K |
|
2607
HNI Corp
HNI
$3.08B
| $4.13M | ﹤0.01% |
116,514
+32,001
| +38% | +$1.21M |
|
2608
Chord Energy
CHRD
$7.83B
| $4.11M | ﹤0.01% |
743,974
-1,012,809
| -58% | -$9.19M |
|
|
HIMX
2609
Himax Technologies
HIMX
$2.19B
| $4.11M | ﹤0.01% |
1,199,462
+1,016,638
| +556% | +$4.8M |
|
|
HSII
2610
DELISTED
Heidrick & Struggles
HSII
| $4.11M | ﹤0.01% |
131,760
-164,906
| -56% | -$5.4M |
|
|
COHR
2611
DELISTED
Coherent Inc
COHR
| $4.11M | ﹤0.01% |
38,832
+10,318
| +36% | +$1.33M |
|
|
OSG
2612
Octave Specialty Group
OSG
$242M
| $4.1M | ﹤0.01% |
237,876
+136,301
| +134% | +$2.5M |
|
|
PRNB
2613
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.1M | ﹤0.01% |
149,549
+134,399
| +887% | +$3.46M |
|
2614
Ingevity
NGVT
$2.52B
| $4.09M | ﹤0.01% |
48,916
-12,097
| -20% | -$1.1M |
|
2615
Inspire Medical Systems
INSP
$1.42B
| $4.08M | ﹤0.01% |
96,683
+92,468
| +2,194% | +$3.93M |
|
2616
Churchill Downs
CHDN
$5.88B
| $4.07M | ﹤0.01% |
100,158
+7,416
| +8% | +$327K |
|
2617
State Street Communication Services Select Sector SPDR ETF
XLC
$22B
| $4.07M | ﹤0.01% |
98,558
+93,855
| +1,996% | +$4.21M |
|
2618
PUT
Skyworks Solutions
SWKS
$9.23B
| $4.06M | ﹤0.01% |
60,600
+7,500
| +14% | +$579K |
|
2619
Fresenius Medical Care
FMS
$13.7B
| $4.05M | ﹤0.01% |
125,136
+37,920
| +43% | +$1.53M |
|
|
BMS
2620
DELISTED
Bemis
BMS
| $4.03M | ﹤0.01% |
87,876
-127,496
| -59% | -$5.94M |
|
|
ATNX
2621
DELISTED
Athenex, Inc. Common Stock
ATNX
| $4.03M | ﹤0.01% |
15,863
+15,354
| +3,017% | +$3.91M |
|
2622
CALL
Allstate
ALL
$68.5B
| $4.02M | ﹤0.01% |
+48,700
| New | +$4.37M |
|
|
FNHC
2623
DELISTED
FedNat Holding Company Common Stock
FNHC
| $4.02M | ﹤0.01% |
201,939
+7,991
| +4% | +$175K |
|
2624
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
| $4.02M | ﹤0.01% |
78,761
+62,875
| +396% | +$3.17M |
|
2625
Hovnanian Enterprises
HOV
$743M
| $4.02M | ﹤0.01% |
235,085
-722
| -0.3% | -$22.9K |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.